Biocon,Mylan get EU approval for biosimilar of cancer drug Medical Dialogues Bureau20 Dec 2018 9:00 AM IST"Ogivri, a biosimilar Trastuzumab jointly developed by Biocon and Mylan, has been approved in the EU. The European Commission has granted marketing...
Mankind Pharma faces setback: Government prohibits Buclizine as Apetite Stimulant Farhat Nasim19 Dec 2018 5:34 PM ISTThis came after the Central Government was satisfied that the use of said drug Buclizine does not have any therapeutic value claimed for as an...
No online sale of drugs till regulatory rules in place: Delhi High Court Farhat Nasim19 Dec 2018 10:33 AM ISTThe observations by the bench were made while hearing the applications moved by some online pharmacies seeking to be impleaded in the matter.New...
Glenmark Pharma gets USFDA nod for Fluocinolone Acetonide Oil Farhat Nasim19 Dec 2018 9:15 AM ISTGlenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for...
Merck strengthens animal health unit with $2.4 billion Antelliq purchase Farhat Nasim19 Dec 2018 9:00 AM ISTThe move affirms Merck's commitment to the business, which Wall Street analysts have long seen value in separating just as rival drugmakers Eli Lilly...
Lupin gets USFDA tentative approval for generic tablets to treat Erectile Dysfunction Medical Dialogues Bureau18 Dec 2018 5:36 PM ISTNew Delhi: Drug maker Lupin recently said it has received tentative approval from the US health regulator for Tadalafil tablets, used to treat...
Lupin gets USFDA nod for generic Clobazam Tablets Farhat Nasim18 Dec 2018 12:29 PM ISTNew Delhi: Pharma major Lupin recently announced that it has received approval for its Clobazam Tablets, 10 mg and 20 mg from the United States Food...
Glenmark pharma gets ANDA approval for Hydrocortisone Valerate Ointment USP, 0 2 pc Medical Dialogues Bureau18 Dec 2018 9:31 AM ISTHydrocortisone Valerate Ointment is Glenmark's first granted competitive generic therapy(CGT) product approved by the FDA.Mumbai: Pharma major...
Junshi Biosciences raises $394 million after pricing IPO at bottom of range Farhat Nasim18 Dec 2018 9:00 AM ISTHONG KONG: Chinese biotech startup Shanghai Junshi Biosciences Co Ltd has raised $394 million after pricing its Hong Kong initial public offering...
J&J announces $5 billion share repurchase after shares extend losses Farhat Nasim18 Dec 2018 8:59 AM ISTThe share repurchase was just the latest effort the healthcare conglomerate has made to boost investor confidence.New Delhi: Johnson & Johnson...
Madras High Court refuses to set aside stay on online sale of drugs Farhat Nasim17 Dec 2018 9:40 AM ISTChennai: The Madras High Court recently refused to set aside the stay order given by it on the issue of the online sale of drugs. It also directed the...
Lupin receives tentative USFDA nod for Dimethyl Fumarate Delayed-Release Capsules Medical Dialogues Bureau17 Dec 2018 9:15 AM ISTNew Delhi: Lupin announced that it has received tentative approval for its Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg from the...
